Altimmune Inc (NAS:ALT)
$ 8.85 0.28 (3.27%) Market Cap: 629.45 Mil Enterprise Value: 471.93 Mil PE Ratio: 0 PB Ratio: 4.71 GF Score: 30/100

Q2 2020 Altimmune Inc Earnings Call Transcript

Aug 12, 2020 / 12:30PM GMT
Release Date Price: $22.58 (-2.25%)
Operator

Greetings, and welcome to the Altimmune, Inc. Second Quarter 2020 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Ms. Monique Kosse, Investor Relations for Altimmune. You may begin.

Monique Kosse
LifeSci Advisors, LLC - MD

Thank you, Melissa, and thank you, everyone, for participating in today's Q2 2020 Earnings Conference Call. Leading the call today will be Dr. Vipin Garg, Chief Executive Officer of Altimmune. Also participating on the call today is Will Brown, Chief Financial Officer; Scot Roberts, Chief Scientific Officer; and Scott Harris, Chief Medical Officer.

After the prepared remarks, we will open up the call for a question-and-answer session. A press release with the Q2 2020 financial results was issued last night and can be found on the Investors page of the company's website.

Before we begin, I would like to remind everyone that remarks about future expectations, plans and prospects constitute forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot